March 6, 2026
1 min read

Lonza hands off capsule business to investment firm Lone Star in $3B deal

Under the deal with Lone Star Funds, Lonza maintains a 40% stake in its capsules and health ingredients business while receiving 1.7 billion Swiss francs ($2.2 billion) upfront.

Leave a Reply

Your email address will not be published.

Previous Story

Some Patients Keep Weight off With Fewer GLP-1 Injections, Study Finds MedNews

Next Story

How Important Is Protein in the Morning?

Previous Story

Some Patients Keep Weight off With Fewer GLP-1 Injections, Study Finds MedNews

Next Story

How Important Is Protein in the Morning?

Latest from Blog

ROFI Drives New Approach to Crop Nutrition

With input costs continuing to pressure farm budgets, some growers are making difficult decisions to reduce fertilizer application rates. While that strategy may ease upfront expenses, it is also accelerating a broader
Go toTop